Vafseo 150 mg
Vafseo 150 mg is a medicine authorised by Swissmedic under authorisation number 68862. The authorisation holder is Salmon Pharma GmbH. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 19 June 2023 and the authorisation is limited until 18 June 2028. ATC code B03XA08 places the medicine in the group Antianemic preparations.
| Authorisation number | 68862 |
|---|---|
| Name | Vafseo 150 mg |
| Full name | Vafseo 150 mg, Filmtabletten |
| Authorisation holder | Salmon Pharma GmbH |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | B03XA08 |
| First authorisation | 19 June 2023 |
| Authorisation validity | 18 June 2028 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Vafseo 150 mg, Filmtabletten | A | 19 June 2023 |
| 2 | Vafseo 300 mg, Filmtabletten | A | 19 June 2023 |
| 3 | Vafseo 450 mg, Filmtabletten | A | 19 June 2023 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 28 | Tablette(n) | B03XA08 | 06.07.3. | A |
| 2 | 98 | Tablette(n) | B03XA08 | 06.07.3. | A |
| 3 | 28 | Tablette(n) | B03XA08 | 06.07.3. | A |
| 4 | 98 | Tablette(n) | B03XA08 | 06.07.3. | A |
| 5 | 28 | Tablette(n) | B03XA08 | 06.07.3. | A |
| 6 | 98 | Tablette(n) | B03XA08 | 06.07.3. | A |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Vafseo 150 mg authorised in Switzerland?
Yes. Vafseo 150 mg is authorised by Swissmedic under authorisation number 68862, data as of 01 September 2026. The authorisation is limited until 18 June 2028.
Which dispensing category does Vafseo 150 mg have?
Vafseo 150 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Vafseo 150 mg?
The authorisation holder is Salmon Pharma GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.